Zen⚡️Chu ⛑🏴‍☠️ (@accelmed) 's Twitter Profile
Zen⚡️Chu ⛑🏴‍☠️

@accelmed

Teaching the next gen of health CEOs + backing early stage med tech ventures @MIT @UCLA @MITHackMed Father to 3 hilarious engineers and a few medical startups.

ID: 88090593

linkhttp://hackingmedicine.mit.edu calendar_today07-11-2009 02:11:48

9,9K Tweet

3,3K Followers

1,1K Following

Ed Livingston (@ehljama) 's Twitter Profile Photo

Anthony DiGiorgio, DO, MHA I totally agree. Many years ago (in the 1990's), when I was Chief of Surgery, I was publicly excoriated by JCAHO reviewers who opened an ortho chart and failed us because the orthopedist did not have a comprehensive family and social history. Never mind that that the team

Avi Roy (@agingroy) 's Twitter Profile Photo

Everyone missed the real China story. While we debated TikTok, Chinese scientists quietly built 1,250 novel drug candidates—up from 160 in 2015. That's not a typo. They added 1,090 innovative medicines in 9 years. The entire EU added 200. Here's how they broke pharma's

Everyone missed the real China story. While we debated TikTok, Chinese scientists quietly built 1,250 novel drug candidates—up from 160 in 2015.

That's not a typo. They added 1,090 innovative medicines in 9 years. The entire EU added 200.

Here's how they broke pharma's
Avi Roy (@agingroy) 's Twitter Profile Photo

But here's what should terrify Western pharma: China solved the industry's biggest bottleneck. Finding patients for clinical trials: 👉US cancer trials: 17.5 months to recruit 👉China: 8.7 months When you can test 2 drugs in the time competitors test 1, compound advantages

But here's what should terrify Western pharma: China solved the industry's biggest bottleneck.

Finding patients for clinical trials:
👉US cancer trials: 17.5 months to recruit
👉China: 8.7 months

When you can test 2 drugs in the time competitors test 1, compound advantages
Avi Roy (@agingroy) 's Twitter Profile Photo

Remember when "Made in China" meant cheap knockoffs? Now, China has more drugs in FDA/EMA expedited review than the entire European Union. These aren't generics—they're potential cures for cancers Keytruda can't touch. Your next life-saving medicine has a 50/50 chance of being

Remember when "Made in China" meant cheap knockoffs?

Now, China has more drugs in FDA/EMA expedited review than the entire European Union. These aren't generics—they're potential cures for cancers Keytruda can't touch.

Your next life-saving medicine has a 50/50 chance of being
Massachusetts Institute of Technology (MIT) (@mit) 's Twitter Profile Photo

Engineers have created a coin‑sized implant that Daniel Anderson says “is always ready to protect patients from low blood sugar.” It senses low glucose, heats a shape‑memory alloy, and releases glucagon - stabilizing blood sugar within 10 minutes. news.mit.edu/2025/implantab…

Mira Murati (@miramurati) 's Twitter Profile Photo

Thinking Machines Lab exists to empower humanity through advancing collaborative general intelligence. We're building multimodal AI that works with how you naturally interact with the world - through conversation, through sight, through the messy way we collaborate. We're

John Doerr (@johndoerr) 's Twitter Profile Photo

It’s hard to imagine a better use for AI than OpenEvidence. Daniel Nadler and his world-class team at OpenEvidence are building what I believe will become an AI-era treasure—a life-saving resource for doctors, patients, and their families. I can’t imagine the future without

Healthcare AI Guy (@healthcareaiguy) 's Twitter Profile Photo

NEW: OpenEvidence, the AI medical assistant, just raised $210M at a $3.5B valuation led by GV & Kleiner Perkins. Now used by 40% of US doctors, it handles 8.5M clinical consults/month. The company also launched DeepConsult, an AI agent for PhD-level evidence syntheses.

NEW: OpenEvidence, the AI medical assistant, just raised $210M at a $3.5B valuation led by GV & Kleiner Perkins.

Now used by 40% of US doctors, it handles 8.5M clinical consults/month. The company also launched DeepConsult, an AI agent for PhD-level evidence syntheses.
Dan O'Neill (@dp_oneill) 's Twitter Profile Photo

The initiative to curb abusive skin substitute billing in the Medicare proposed PFS rule is highly technical, but also raises an interesting question: How does the political economy of health spending change when a large constituency of providers has an interest in lower costs?

Eric Topol (@erictopol) 's Twitter Profile Photo

Internet search traffic for health information has dropped precipitously, the outlier vs drop in all other categories, as chatbots and genAI take hold economist.com/business/2025/…

Internet search traffic for health information has dropped precipitously, the outlier vs drop in all other categories, as chatbots and genAI take hold
economist.com/business/2025/…
Grok (@grok) 's Twitter Profile Photo

Johngalt2024 Acyn Ted Kaczynski, the Unabomber, was a math prodigy turned domestic terrorist who mailed bombs from 1978-1995, killing 3 and injuring 23. Trump claims his uncle John taught him at MIT, but that's false—Kaczynski attended Harvard and Michigan, with no MIT connection. Geniuses and

Molecule (@molecule_dao) 's Twitter Profile Photo

"Molecule didn't just talk about fixing science. They built the infrastructure for it." Science has always been progressing - from the Enlightenment Age to the Space Race, we have always pushed boldly forward. DeSci is the next gen. x.com/queenEddie001/…

Forbes (@forbes) 's Twitter Profile Photo

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 million at a $3.5 billion valuation. (Photo: Mauricio Candela for Forbes) trib.al/g95Pd2a

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 million at a $3.5 billion valuation. (Photo: Mauricio Candela for Forbes) trib.al/g95Pd2a
Paul Kohlhaas bio/acc (@paulkhls) 's Twitter Profile Photo

you spent the past 6 months chasing the white rabbit 🐇into agentic system with snowball ElizaOS frameworks Olas (formerly Autonolas) FutureHouse Sakana AI ? We are looking for agent engineers and PMs to join our Bio Protocol AI team Can be non-technical / vibe coders. 1 ETH bounty 🤖

Paul Kohlhaas bio/acc (@paulkhls) 's Twitter Profile Photo

What if I told you we are onboarding the most prominent US scientists to tokenise and agentify their life’s work on Bio Protocol Who would you like to see become a top tier funded scientist, lab or community - tag them if you get any of them right I’ll airdrop you 1000 $BIO 👩‍🔬👨‍🔬

Isaac Kohane (@zakkohane) 's Twitter Profile Photo

Poignant and insightful view by medical students on the impact of AI and the role of humans in clinical care NEJM AI ai.nejm.org/doi/10.1056/AI… We need to figure out how to make students like these our future leaders in healthcare.

Nikhil Krishnan (@nikillinit) 's Twitter Profile Photo

I listened to this planet money podcast on the university funding cuts - one interesting tidbit i learned here is that for a lot of these schools the big revenue generator is hospital services they look through the line items of WashU and it’s 50% of their revenue

I listened to this planet money podcast on the university funding cuts - one interesting tidbit i learned here is that for a lot of these schools the big revenue generator is hospital services

they look through the line items of WashU and it’s 50% of their revenue